A Urinary Tumor Marker (Kidney Injury Molecule-1) for the Detection of Renal Cell Carcinoma

Stopped early

Conditions studied: Renal Cell Carcinoma

In brief

The ultimate goal of this project is to develop a simple non-invasive method to screen patients for potential kidney tumors.

Key facts

Study ID

NCT01063998

Run by

Jason Hafron

People needed

23

Starts

2009-09-01

Expected to finish

2012-03-01

Last updated by the study team

2013-11-08

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients demonstrate normal serum creatinine and no radiological evidence of a renal tumor.
• OR
• Patients diagnosed with renal cancer and normal creatinine.

You may not qualify if…

• None.

Where it is running

• Beaumont Hospitals — Royal Oak, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.